tm
Seeing Is Believing
tm
Seeing Is Believing
AUPH is currently covered by 3 analysts with an average price target of $22.52. This is a potential upside of $8.35 (58.93%) from yesterday's end of day stock price of $14.17.
Aurinia Pharmaceuticals's activity chart (see below) currently has 114 price targets and 69 ratings on display. The stock rating distribution of AUPH is 50% BUY and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 68.58% with an average time for these price targets to be met of 414.63 days.
Highest price target for AUPH is $21, Lowest price target is $9, average price target is $15.33.
Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 03-Dec-2025. First documented stock forecast 30-Jun-2016.
Currently out of the existing stock ratings of AUPH, 2 are a BUY (50%), 2 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Dec-2025
$16
$1.83 (12.91%)
$12
2 months 27 days ago
(03-Dec-2025)
2/5 (40%)
$1.09 (7.31%)
141
Buy Since 07-Nov-2025
$21
$6.83 (48.20%)
$6
3 months 23 days ago
(07-Nov-2025)
3/4 (75%)
$6.39 (43.74%)
398
Hold Since 04-Nov-2025
$9
$-5.17 (-36.49%)
$8
3 months 26 days ago
(04-Nov-2025)
9/14 (64.29%)
$-5.27 (-36.93%)
135
Buy Since 16-Mar-2020
$13
$-1.17 (-8.26%)
$13
1 years 5 months 24 days ago
(06-Sep-2024)
16/22 (72.73%)
$5.74 (79.06%)
626
Hold Since 04-Nov-2022
$13
3 years 3 months 26 days ago
(04-Nov-2022)
6/9 (66.67%)
$4.73 (57.19%)
359
What is AUPH (Aurinia Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on AUPH (Aurinia Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on AUPH (Aurinia Pharmaceuticals)?
Which analyst is the currently most bullish on AUPH (Aurinia Pharmaceuticals)?
Which analyst is the currently most reserved on AUPH (Aurinia Pharmaceuticals)?
